NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

Health & Medicine Week

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Health & Medicine Week

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Antifungal Research



Gallerimycin, a moth-derived antifungal peptide, isn't active against yeast



September 1st, 2003

A new antifungal discovered in wax moth, gallerimycin, is not active against yeast.

According to published research from Germany, "A novel defensin-like peptide was identified in the greater wax moth, Galleria mellonella. It was discovered in a hemocyte cDNA bank enriched with transcripts upregulated after immune challenge via subtractive hybridization and suppressive PCR.

"The deduced amino acid (aa) sequence of the defensin-like peptide exhibits similarities to the antifungal peptides drosomycin from Drosophila melonogaster and heliomicin from Heliothis virescens. Therefore, it has been termed gallerimycin. Upregulation of...


Source: Health & Medicine Week (2003-09-01)

NewsRx Passes
Advertisement
More Articles

------------------------
Security by Verisign PR Login